Natriuretic peptides in unstable coronary artery disease

European Heart Journal

Volumn 25, Issue 17, 2004, Pages 1486-1493

  Jernberg, Tomas ^a   James, Stefan ^a   Lindahl, Bertil ^a   Johnston, Nina ^a   Stridsberg, Mats ^b   Venge, Per ^b   Wallentin, Lars ^a  

^a University in Sweden   (Sweden)

^b Clinical Chemistry   (Sweden)

Author keywords

Myocardial infarction; Natriuretic peptide; Prognosis; Unstable angina

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; HORMONE PRECURSOR; N TERMINAL PRODOMAIN NATRIURETIC PEPTIDE; NATRIURETIC PEPTIDE TYPE C; PEPTIDE DERIVATIVE; TROPONIN T; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; ANGINA PECTORIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DISEASE MARKER; HALF LIFE TIME; HEART MUSCLE INJURY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DYSFUNCTION; MORBIDITY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SURVIVAL;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; HUMANS; NATRIURETIC PEPTIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 4444358454     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.06.017     Document Type: Review

References (47)

1. K.A. Fox, S.G. Goodman, and W. Klein Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE) Eur. Heart J. 23 2002 1177 1189
2. D. Hasdai, S. Behar, and L. Wallentin A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur. Heart J. 23 2002 1190 1201
3. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N. Engl. J. Med. 344 2001 1879 1887
4. E. Diderholm, B. Andren, and G. Frostfeldt The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy Am. Heart J. 143 2002 760 767
5. M.E. Bertrand, M.L. Simoons, and K.A. Fox Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur. Heart J. 23 2002 1809 1840
6. B. Lindahl, H. Toss, and A. Siegbahn Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N. Engl. J. Med. 343 2000 1139 1147
7. J. Al Suwaidi, D.N. Reddan, and K. Williams Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes Circulation 106 2002 974 980
8. J. Berning, F. Steensgaard-Hansen, and M. Appleyard Relative prognostic value of clinical heart failure and early echocardiographic parameters in acute myocardial infarction Cardiology 79 1991 64 72
9. M. St John Sutton, M.A. Pfeffer, and T. Plappert Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril Circulation 89 1994 68 75
10. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
11. G.A. Sagnella Measurement and significance of circulating natriuretic peptides in cardiovascular disease Clin. Sci. (Lond.) 95 1998 519 529
12. J. Mair, W. Friedl, S. Thomas, and B. Puschendorf Natriuretic peptides in assessment of left-ventricular dysfunction Scand. J. Clin. Lab. Invest. Suppl. 230 1999 132 142
13. F. Boomsma, and A.H. van den Meiracker Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use Cardiovasc. Res. 51 2001 442 449
14. M. Davis, E. Espiner, and G. Richards Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 1994 440 444
15. M.R. Cowie, A.D. Struthers, and D.A. Wood Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
16. S. Talwar, I.B. Squire, and J.E. Davies Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population Eur. Heart J. 20 1999 1736 1744
17. A.S. Maisel, J. Koon, and P. Krishnaswamy Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction Am. Heart J. 141 2001 367 374
18. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N. Engl. J. Med. 347 2002 161 167
19. B.A. Groenning, J.C. Nilsson, and L. Sondergaard Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations Am. Heart J. 143 2002 923 929
20. B. Stanek, B. Frey, and M. Hulsmann Prognostic evaluation of neurohumoral plasma levels before and during β-blocker therapy in advanced left ventricular dysfunction J. Am. Coll. Cardiol. 38 2001 436 442
21. A.M. Richards, R. Doughty, and M.G. Nicholls Plasma N-terminal pro-brain natriuretic peptide and adrenomedullina* prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction J. Am. Coll. Cardiol. 37 2001 1781 1787
22. R.W. Troughton, C.M. Frampton, and T.G. Yandle Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Lancet 355 2000 1126 1130
23. P.J. Hunt, A.M. Richards, and M.G. Nicholls Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment Clin. Endocrinol. (Oxf.) 47 1997 287 296
24. A. Hammerer-Lercher, E. Neubauer, and S. Muller Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction Clin. Chim. Acta 310 2001 193 197
25. S. Masson, T. Vago, and G. Baldi Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure Clin. Chem. Lab. Med. 40 2002 761 763
26. J.G. Motwani, H. McAlpine, and N. Kennedy Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction Lancet 341 1993 1109 1113
27. A.M. Choy, D. Darbar, and C.C. Lang Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods Br. Heart J. 72 1994 16 22
28. D. Darbar, N.C. Davidson, and N. Gillespie Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction Am. J. Cardiol. 78 1996 284 287
29. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
30. A.M. Richards, M.G. Nicholls, and T.G. Yandle Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
31. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N. Engl. J. Med. 345 2001 1014 1021
32. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic eptide and prognosis in TACTICS-TIMI 18 J. Am. Coll. Cardiol. 41 2003 1264 1272
33. T. Jernberg, M. Stridsberg, and P. Venge N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J. Am. Coll. Cardiol. 40 2002 437 445
34. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
35. S.K. James, B. Lindahl, and A. Siegbahn N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
36. J. Tateishi, M. Masutani, and M. Ohyanagi Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty Clin. Cardiol. 23 2000 776 780
37. K. Marumoto, M. Hamada, and K. Hiwada Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris Clin. Sci. (Lond.) 88 1995 551 556
38. R. Berger, M. Huelsman, and K. Strecker B-type natriuretic peptide predicts sudden death in patients with chronic heart failure Circulation 105 2002 2392 2397
39. M.S. O'Mahony, M.F. Sim, and S.F. Ho Diastolic heart failure in older people Age Ageing 32 2003 519 524
40. S. Maffei, S. Del Ry, and C. Prontera Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women Clin. Sci. (Lond) 101 2001 447 453
41. H. Sayama, Y. Nakamura, and N. Saito Why is the concentration of plasma brain natriuretic peptide in elderly inpatients greater than normal? Coron. Artery Dis. 10 1999 537 540
42. N. Johnston, T. Jernberg, and B. Lindahl Biochemical indicators of cardiac and renal function in a healthy elderly population Clin. Biochem. 37 2004 210 216
43. T.J. Wang, M.G. Larson, and D. Levy Impact of age and sex on plasma natriuretic peptide levels in healthy adults Am. J. Cardiol. 90 2002 254 258
44. M.M. Redfield, R.J. Rodeheffer, and S.J. Jacobsen Plasma brain natriuretic peptide concentration: impact of age and gender J. Am. Coll. Cardiol. 40 2002 976 982
45. T. Jernberg, B. Lindahl, and A. Siegbahn N-terminal pro brain natriuretic peptide in relation to inflammation, myocardial necrosis and the effect of an invasive strategy in unstable coronary artery disease J. Am. Coll. Cardiol. 42 2003 1909 1916
46. E. Morita, H. Yasue, and M. Yoshimura Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction Circulation 88 1993 82 91
47. N. Arakawa, M. Nakamura, and H. Aoki Relationship between plasma level of brain natriuretic peptide and myocardial infarct size Cardiology 85 1994 334 340